0001193125-17-025548.txt : 20170131 0001193125-17-025548.hdr.sgml : 20170131 20170131153002 ACCESSION NUMBER: 0001193125-17-025548 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170131 DATE AS OF CHANGE: 20170131 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89517 FILM NUMBER: 17560927 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Hoffman Marguerite CENTRAL INDEX KEY: 0001676132 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: C/O DON STUART STREET 2: 221 WEST 6TH STREET, SUITE 1300 CITY: AUSTIN STATE: TX ZIP: 78701 SC 13G/A 1 d338682dsc13ga.htm SC 13G/A SC 13G/A

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)

 

 

Reata Pharmaceuticals, Inc.

(Name of Issuer)

Class A Common Stock, $0.001 par value

(Title of Class of Securities)

75615P 103

(CUSIP Number)

December 31, 2016

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

 

☒ Rule 13d-1(c)

 

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP NO. 75615P 103  

 

  1   

Name of Reporting Person:

 

Marguerite Steed Hoffman

  2  

Check the Appropriate Box if a Member of a Group

(a)  ☐        (b)  ☐

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

      5    

Sole Voting Power

 

470,766 (a)

     6   

Shared Voting Power

 

0

     7   

Sole Dispositive Power

 

470,766 (a)

     8   

Shared Dispositive Power

 

0

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

470,766

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

☐

11  

Percent of Class Represented by Amount in Row (9)

 

5.3% (b)

12  

Type of Reporting Person

 

IN

 

(a) Includes 470,766 shares of Class A common stock, par value $0.001 per share (“Class A Common Stock”) of Reata Pharmaceuticals, Inc. (the “Issuer”), each such share of Class A Common Stock held directly by Ms. Hoffman and over which she exercises sole voting and dispositive power.
(b) Based on 8,949,660 shares of Class A Common Stock outstanding.

Item 1(a). Name of issuer: Reata Pharmaceuticals, Inc. (the “Issuer”)

 

Item 1(b). Address of issuer’s principal executive offices:

 

     2801 Gateway Drive, Suite 150
     Irving, Texas 75063

 

Item 2(a). Names of persons filing:

 

     Marguerite Steed Hoffman

 

Item 2(b). Address or principal business office or, if none, residence:

 

     The business address of Ms. Hoffman is c/o Don Stuart, 221 West 6th Street, Suite 1300, Austin, Texas 78701.

 

Item 2(c). Citizenship:

 

     Ms. Hoffman is a United States citizen.

 

Item 2(d). Title of class of securities: Class A Common Stock, par value $0.001 (“Class A Common Stock”)

 

Item 2(e). CUSIP number: 75615P 103

 

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not applicable.

 

Item 4. Ownership:

 

     Ms. Hoffman may be deemed to beneficially own 470,766 shares of Class A Common Stock, representing approximately 5.3% of the outstanding shares of Class A Common Stock.

 

     Ms. Hoffman may be deemed to have sole voting and dispositive power with respect to 470,766 shares of Class A Common Stock.

 

Item 5. Ownership of five percent or less of a class: Not applicable.

 

Item 6. Ownership of more than five percent on behalf of another person: Not applicable.

 

Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person: Not applicable.

 

Item 8. Identification and classification of members of the group: Not applicable.

 

Item 9. Notice of dissolution of group: Not applicable.

 

Item 10. Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of his or her knowledge and belief, undersigned certifies that the information with respect to it set forth in this statement is true, complete and correct.

 

Dated: January 31, 2017     Marguerite Steed Hoffman
    By:  

/s/ Donald L. Stuart

    Name:   Donald L. Stuart
    Title:   Attorney-in-fact

LIST OF EXHIBITS

 

Exhibit No.

   

Description

24.1    Power of Attorney (incorporated by reference to Exhibit 24.1 of the Schedule 13G filed by the Reporting Person on June 6, 2016).